ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
Regulating Enzyme Activity via Microaggregates Mediated by Phase Separation.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Regulating Enzyme Activity via Microaggregates Mediated by Phase Separation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Liquid-solid phase separation (LSPS) is a biomolecular segregation process forming solid-like aggregates that encapsulate and concentrate specific biomolecules, thus profoundly influencing biochemical reactions. Building on this phenomenon, we developed an enzyme-regulation strategy inducing LSPS of target enzymes to isolate them from substrates. As proof of concept, we created a novel D-Peptide mediated Microaggregate Degradation named DPMD to capture trypsin and chymotrypsin in the seroperitoneum during postoperative pancreatic fistula (POPF). DPMD is designed with cationic and hydrophobic residues and a β-sheet-forming motif for specific binding. The core principle is an entropy-driven peptide self-assembly that sequesters these proteases from the extracellular environment. Captured enzymes form intricate peptide-enzyme microaggregates, effectively segregating them from substrates. These microaggregates are readily internalized and cleared by macrophages, likely via macropinocytosis. In rat POPF models, DPMD significantly reduced pancreatic fluid leakage and inflammatory markers, improved survival, and outperformed a conventional L-peptide control. Toxicity evaluations showed DPMD was well tolerated even at doses beyond therapeutic levels, underscoring its favorable safety profile. In summary, this study demonstrates a significant translational advance in POPF treatment and expands our understanding of pathogenic enzyme sequestration via LSPS, potentially opening new therapeutic avenues for a range of enzyme-mediated diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.